Neuropace Inc Financial Flexibility Index
Neuropace Inc financial flexibility index. Neuropace Inc (NPCE) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-3.78 Million (operating CF $-3.90 Million minus capex $125.00K) represents 0% of total liabilities ($85.11 Million). See Neuropace Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Neuropace Inc (2019–2025)
Financial flexibility index of Neuropace Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Neuropace Inc across 7 annual periods. Explore debt repayment capacity of Neuropace Inc to assess how comfortably operating cash covers total debt obligations.
Neuropace Inc Financial Flexibility Index by Year (2019–2025)
Neuropace Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Neuropace Inc. For the full cash flow conversion analysis, see how efficiently does Neuropace Inc generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-10.67 Million | $-11.01 Million | $86.53 Million | ▲ +39.4% |
| 2024 | -0.20x | $-17.64 Million | $-17.95 Million | $86.63 Million | ▲ +9.3% |
| 2023 | -0.22x | $-19.53 Million | $-19.70 Million | $87.00 Million | ▲ +50.9% |
| 2022 | -0.46x | $-36.27 Million | $-36.87 Million | $79.33 Million | ▼ -13.5% |
| 2021 | -0.40x | $-24.19 Million | $-24.58 Million | $60.06 Million | ▼ -281.0% |
| 2020 | -0.11x | $-21.55 Million | $-21.61 Million | $203.78 Million | ▲ +35.2% |
| 2019 | -0.16x | $-24.56 Million | $-25.03 Million | $150.44 Million | — |